(Q53206626)

12 May 2018

editorial

0 references

title

Role of amyloid β1-42 and neuroimaging biomarkers in Alzheimer's disease. (English)

1 reference

12 May 2018

0 references

1 reference

2

1 reference

12 May 2018

author name string

Simone Lista

series ordinal

1

1 reference

12 May 2018

publication date

1 August 2011

1 reference

12 May 2018

published in

Biomarkers in Medicine

1 reference

12 May 2018

volume

5

1 reference

12 May 2018

issue

4

1 reference

12 May 2018

page(s)

411-413

1 reference

12 May 2018

Worldwide variation in the doubling time of Alzheimer's disease incidence rates

cites work

1 reference

21 January 2018

1 reference

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

21 January 2018

1 reference

21 January 2018

1 reference

Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease

21 January 2018

1 reference

Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

21 January 2018

1 reference

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

21 January 2018

1 reference

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease

21 January 2018

1 reference

Diagnosis and biomarkers of predementia in Alzheimer's disease.

21 January 2018

1 reference

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study

21 January 2018

1 reference

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

21 January 2018

1 reference

CSF markers for incipient Alzheimer's disease

21 January 2018

1 reference

Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry

21 January 2018

1 reference

Optimization protocol for amyloid-β peptides detection in human cerebrospinal fluid using SELDI TOF MS.

21 January 2018

1 reference

Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI).

21 January 2018

1 reference

The Alzheimer's disease neuroimaging initiative

21 January 2018

1 reference

Do CSF biomarkers help clinicians predict the progression of mild cognitive impairment to dementia?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/BMM.11.50

1 reference

12 May 2018

1 reference

12 May 2018